Cargando…
Combined oral administration of L-arginine and tetrahydrobiopterin in a rat model of pulmonary arterial hypertension
Alterations in the nitric oxide (NO) pathway play a major role in pulmonary arterial hypertension (PAH). L-arginine (LA) and tetrahydrobiopterin (BH(4)) are main substrates in the production of NO, which mediates pulmonary vasodilation. Administration of either LA or BH(4) decrease pulmonary artery...
Autores principales: | Schreiber, C., Eilenberg, M.S., Panzenboeck, A., Winter, M.P., Bergmeister, H., Herzog, R., Mascherbauer, J., Lang, I.M., Bonderman, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448548/ https://www.ncbi.nlm.nih.gov/pubmed/28680568 http://dx.doi.org/10.1086/689289 |
Ejemplares similares
-
Splenectomy Is Modifying the Vascular Remodeling of Thrombosis
por: Frey, Maria K., et al.
Publicado: (2014) -
Is tetrahydrobiopterin a therapeutic option in diabetic hypertensive patients?
por: Rubio-Guerra, Alberto Francisco, et al.
Publicado: (2010) -
Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction: Study protocol for a randomized controlled trial
por: Mascherbauer, Julia, et al.
Publicado: (2016) -
Cumulative effect of simvastatin, l-arginine, and tetrahydrobiopterin on cerebral blood flow and cognitive function in Alzheimer’s disease
por: Degrush, Elizabeth, et al.
Publicado: (2022) -
Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial( )
por: Dachs, Theresa Marie, et al.
Publicado: (2022)